C. Delcayre and J. Silvestre, Aldosterone and the heart: towards a physiological function?, Cardiovascular Research, vol.43, issue.1, pp.7-12, 1999.
DOI : 10.1016/S0008-6363(99)00088-7

B. Pitt, F. Zannad, W. J. Remme, R. Cody, A. Castaigne et al., The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure, New England Journal of Medicine, vol.341, issue.10, pp.709-717, 1999.
DOI : 10.1056/NEJM199909023411001

M. Gomberg-maitland, D. A. Baran, and V. Fuster, Treatment of Congestive Heart Failure, Archives of Internal Medicine, vol.161, issue.3, pp.342-352, 2001.
DOI : 10.1001/archinte.161.3.342

M. Lombes, N. Alfaidy, E. Eugene, A. Lessana, N. Farman et al., Prerequisite for Cardiac Aldosterone Action : Mineralocorticoid Receptor and 11??-Hydroxysteroid Dehydrogenase in the Human Heart, Circulation, vol.92, issue.2, pp.175-182, 1995.
DOI : 10.1161/01.CIR.92.2.175

D. J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz et al., The nuclear receptor superfamily: The second decade, Cell, vol.83, issue.6, pp.835-839, 1995.
DOI : 10.1016/0092-8674(95)90199-X

URL : http://doi.org/10.1016/0092-8674(95)90199-x

D. S. Geller, A. Farhi, N. Pinkerton, M. Fradley, M. Moritz et al., Activating Mineralocorticoid Receptor Mutation in Hypertension Exacerbated by Pregnancy, Science, vol.289, issue.5476, pp.119-123, 2000.
DOI : 10.1126/science.289.5476.119

S. Berger, M. Bleich, W. Schmid, T. J. Cole, J. Peters et al., Mineralocorticoid receptor knockout mice: Pathophysiology of Na+ metabolism, Proceedings of the National Academy of Sciences, vol.1, issue.8059, pp.9424-9429, 1998.
DOI : 10.1016/S0140-6736(78)90070-3

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC21354

U. Baron, S. Freundlieb, M. Gossen, and H. Bujard, Co-regulation of two gene activities by tetracycline via a bidirectional promoter, Nucleic Acids Research, vol.23, issue.17, pp.3605-3606, 1995.
DOI : 10.1093/nar/23.17.3605

Z. Yu, C. S. Redfern, and G. Fishman, Conditional Transgene Expression in the Heart, Circulation Research, vol.79, issue.4, pp.691-697, 1996.
DOI : 10.1161/01.RES.79.4.691

Y. Gavrieli, Y. Sherman, and S. A. Ben-sasson, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, The Journal of Cell Biology, vol.119, issue.3, pp.493-501, 1992.
DOI : 10.1083/jcb.119.3.493

V. Robert, J. S. Silvestre, D. Charlemagne, A. Sabri, P. Trouve et al., Biological Determinants of Aldosterone-Induced Cardiac Fibrosis in Rats, Hypertension, vol.26, issue.6, pp.971-978, 1995.
DOI : 10.1161/01.HYP.26.6.971

C. Pollick, S. L. Hale, and R. A. Kloner, Echocardiographic and cardiac doppler assessment of mice, Journal of the American Society of Echocardiography, vol.8, issue.5, pp.602-610, 1995.
DOI : 10.1016/S0894-7317(05)80373-6

D. J. Sahn, A. Demaria, J. Kisslo, and A. Weyman, Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements, Circulation, vol.58, issue.6, pp.1072-1083, 1978.
DOI : 10.1161/01.CIR.58.6.1072

U. Baron and H. Bujard, Tet repressor-based system for regulated gene expression in eukaryotic cells: Principles and advances, Methods Enzymol, vol.327, pp.401-421, 2000.
DOI : 10.1016/S0076-6879(00)27292-3

R. P. Erickson, Antisense Transgenics in Animals, Methods, vol.18, issue.3, pp.304-310, 1999.
DOI : 10.1006/meth.1999.0788

G. Fishman, Timing Is Everything in Life : Conditional Transgene Expression in the Cardiovascular System, Circulation Research, vol.82, issue.8, pp.837-844, 1998.
DOI : 10.1161/01.RES.82.8.837

M. Young, M. Fullerton, R. Dilley, and J. Funder, Mineralocorticoids, hypertension, and cardiac fibrosis., Journal of Clinical Investigation, vol.93, issue.6, pp.2578-2583, 1994.
DOI : 10.1172/JCI117269

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC294488

V. Gross, T. Walther, A. F. Milia, K. Walter, W. Schneider et al., Left ventricular function in mice lacking the AT2 receptor, Journal of Hypertension, vol.19, issue.5, pp.967-976, 2001.
DOI : 10.1097/00004872-200105000-00018

H. Peng, O. A. Carretero, M. E. Alfie, J. A. Masura, and N. Rhaleb, Effects of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Type 1 Receptor Antagonist in Deoxycorticosterone Acetate-Salt Hypertensive Mice Lacking Ren-2 Gene, Hypertension, vol.37, issue.3, pp.974-980, 2001.
DOI : 10.1161/01.HYP.37.3.974

W. Mamuya, A. Chobanian, and P. Brecher, Age-related changes in fibronectin expression in spontaneously hypertensive, Wistar-Kyoto, and Wistar rat hearts, Circulation Research, vol.71, issue.6, pp.1341-1350, 1992.
DOI : 10.1161/01.RES.71.6.1341

L. Menuet, D. Isnard, R. Bichara, M. Viengchareun, S. Muffat-joly et al., Alteration of Cardiac and Renal Functions in Transgenic Mice Overexpressing Human Mineralocorticoid Receptor, Journal of Biological Chemistry, vol.276, issue.42, pp.38911-38920, 2001.
DOI : 10.1074/jbc.M103984200

F. J. Ramires, A. Mansur, O. Coelho, M. Maranhao, C. J. Gruppi et al., Effect of Spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy, The American Journal of Cardiology, vol.85, issue.10, pp.1207-1211, 2000.
DOI : 10.1016/S0002-9149(00)00729-3

C. H. Redfern, M. Y. Degtyarev, A. T. Kwa, N. Salomonis, N. Cotte et al., Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy, Proceedings of the National Academy of Sciences, vol.20, issue.2, pp.4826-4831, 2000.
DOI : 10.1023/A:1005393501786